Leon C.G. Liu

Leon C.G. Liu

McDermott Will & Emery

Contact  |  View Bio  |  RSS

Latest Publications

Share:

China Compliance Update: Commercial Bribery Risks Remain Very Real in China

The enactment of new legislation, as well as new and continuing investigations, demonstrates that Chinese regulators have not slowed down their efforts to ferret out corruption in the pharmaceutical sector and related...more

2/13/2014 - Bribery China Compliance Foreign Official White Collar Crimes

China’s Campaign Against Bribery and Corruption Takes a New Turn: A Focus on Information Gathering

Recently, the co-founders of a firm primarily engaged in investigation-related services were arrested in Shanghai. The arrest indicates protected information laws are being rigorously enforced in China, and could signal a...more

10/1/2013 - Bribery China Compliance Corruption Criminal Prosecution Data Collection Data Protection Personally Identifiable Information

Whistleblowing in China and the United States

The Chinese Government’s wide-ranging bribery and corruption investigation into the pharmaceutical industry takes a new turn every week. Media reports contain numerous incidents of purported whistleblowers making allegations...more

8/30/2013 - Bribery China Compliance Corruption Dodd-Frank False Claims Act Pharmaceutical Risk Management Whistleblower Awards Whistleblowers

Observations on a Milestone Bribery Investigation and Increased Scrutiny of Foreign Companies in China

The Chinese government’s recent crackdown on alleged bribery and corruption of local officials by multinational pharmaceutical companies could signal a broad trend toward elevated scrutiny of all foreign corporations...more

7/30/2013 - Bribery China Compliance Corruption Due Diligence FCPA Foreign Corporations GlaxoSmithKline UK Bribery Act

4 Results
|
View per page
Page: of 1